Conference
BIOMARKER ANALYSIS OF NCIC CLINICAL TRIALS GROUP IND.196, A PHASE I STUDY OF ERLOTINIB PLUS FORETINIB IN ADVANCED PRETREATED NON-SMALL CELL LUNG CANCER PATIENTS
Authors
Leighl N; Tsao MS; Sakashita S; Tu D; Ho C; Shepherd FA; Murray N; Nicholas G; Goffin JR; Kim L
Volume
8
Pagination
pp. S330-S331
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
November 1, 2013
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
ISSN
1556-0864